Georgina Jacko, Aarany Sivakaanthan, Peter Cunningham, James Daly, Helen Liley
{"title":"探讨献血者性别对澳大利亚极低出生体重儿结局的影响。","authors":"Georgina Jacko, Aarany Sivakaanthan, Peter Cunningham, James Daly, Helen Liley","doi":"10.1111/vox.70065","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Despite many known benefits of red blood cell (RBC) transfusions for very low birth weight (VLBW) infants, there is increasing concern that they may be associated with adverse clinical outcomes and that donor characteristics (including donor sex) could contribute to these adverse outcomes.</p><p><strong>Materials and methods: </strong>Outcomes of a 7-year (2016-2022) retrospective cohort of VLBW preterm infants born at Mater Mothers' Hospital who received at least one RBC transfusion and no other blood products were assessed. While adjusting for the number of transfusions administered to each neonate, we investigated the association between donor sex (expressed as the proportion of transfused RBC units collected from female donors) and standardized morbidity outcomes that are reported to the Australian and New Zealand Neonatal Network. These outcomes include bronchopulmonary dysplasia, late onset infection, retinopathy of prematurity and mortality.</p><p><strong>Results: </strong>Analysis including 394 neonates who received a total of 820 RBC transfusions did not identify any statistically significant associations between blood donor sex and the outcomes of interest.</p><p><strong>Conclusion: </strong>Our findings support the continued practice of administration of RBC transfusions to Australian VLBW neonates without consideration of blood donor sex. Further large, prospective, multi-centre studies are recommended to enhance the level of evidence addressing this clinical concern.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"921-927"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12422830/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the influence of blood donor sex on outcomes in Australian very low birth weight infants.\",\"authors\":\"Georgina Jacko, Aarany Sivakaanthan, Peter Cunningham, James Daly, Helen Liley\",\"doi\":\"10.1111/vox.70065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Despite many known benefits of red blood cell (RBC) transfusions for very low birth weight (VLBW) infants, there is increasing concern that they may be associated with adverse clinical outcomes and that donor characteristics (including donor sex) could contribute to these adverse outcomes.</p><p><strong>Materials and methods: </strong>Outcomes of a 7-year (2016-2022) retrospective cohort of VLBW preterm infants born at Mater Mothers' Hospital who received at least one RBC transfusion and no other blood products were assessed. While adjusting for the number of transfusions administered to each neonate, we investigated the association between donor sex (expressed as the proportion of transfused RBC units collected from female donors) and standardized morbidity outcomes that are reported to the Australian and New Zealand Neonatal Network. These outcomes include bronchopulmonary dysplasia, late onset infection, retinopathy of prematurity and mortality.</p><p><strong>Results: </strong>Analysis including 394 neonates who received a total of 820 RBC transfusions did not identify any statistically significant associations between blood donor sex and the outcomes of interest.</p><p><strong>Conclusion: </strong>Our findings support the continued practice of administration of RBC transfusions to Australian VLBW neonates without consideration of blood donor sex. Further large, prospective, multi-centre studies are recommended to enhance the level of evidence addressing this clinical concern.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"921-927\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12422830/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70065\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70065","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Exploring the influence of blood donor sex on outcomes in Australian very low birth weight infants.
Background and objectives: Despite many known benefits of red blood cell (RBC) transfusions for very low birth weight (VLBW) infants, there is increasing concern that they may be associated with adverse clinical outcomes and that donor characteristics (including donor sex) could contribute to these adverse outcomes.
Materials and methods: Outcomes of a 7-year (2016-2022) retrospective cohort of VLBW preterm infants born at Mater Mothers' Hospital who received at least one RBC transfusion and no other blood products were assessed. While adjusting for the number of transfusions administered to each neonate, we investigated the association between donor sex (expressed as the proportion of transfused RBC units collected from female donors) and standardized morbidity outcomes that are reported to the Australian and New Zealand Neonatal Network. These outcomes include bronchopulmonary dysplasia, late onset infection, retinopathy of prematurity and mortality.
Results: Analysis including 394 neonates who received a total of 820 RBC transfusions did not identify any statistically significant associations between blood donor sex and the outcomes of interest.
Conclusion: Our findings support the continued practice of administration of RBC transfusions to Australian VLBW neonates without consideration of blood donor sex. Further large, prospective, multi-centre studies are recommended to enhance the level of evidence addressing this clinical concern.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.